E. Nelaj, I. Kecaj, J. Feracaku, K. Xhixhabesi, and M. Tase, “Benefits of SGLT2 inhibitors on renal and cardiovascular protection, in diabetic patients”, SEEJPH, pp. 200–206, Aug. 2024.